Nu Skin Enterprises (NUS) Common Equity (2009 - 2026)

Nu Skin Enterprises has disclosed Common Equity across 18 years of filings, most recently posting $542.7 million for Q2 2026.

• In Q2 2026, Common Equity fell 31.1% year-over-year to $542.7 million; the TTM figure through Jun 2026 stood at $542.7 million (down 31.1% YoY), while the FY2025 annual figure was $805.2 million, up 23.61% from the prior year.
• Common Equity came in at $542.7 million for Q2 2026 at Nu Skin Enterprises, down from $794.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $941.0 million in Q2 2022 to a low of $542.7 million in Q2 2026.
• Average Common Equity over 5 years is $799.2 million, with a median of $807.7 million recorded in 2024.
• Year-over-year, Common Equity gained 23.61% in 2025 and sank 31.1% in 2026.
• Over 5 years, Common Equity stood at $897.3 million in 2022, then dropped by 8.4% to $822.0 million in 2023, then slipped by 20.74% to $651.5 million in 2024, then grew by 23.61% to $805.2 million in 2025, then sank by 32.6% to $542.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $542.7 million in Q2 2026, $794.1 million in Q1 2026, and $805.2 million in Q4 2025.